Explore key developments in genetic aortopathy through this conference session from the 2023 Rare Cardiac Conditions Conference, moderated by cardiac surgeon Dr. Munir Boodhwani and medical geneticist Dr. Julie Richer. Learn about the latest updates from the 2022 AHA/ACC guidelines presented by Dr. Kenza Rahmouni, followed by an engaging group discussion. Gain insights into bridging the evidence gap in aortic disease through Dr. Boodhwani's presentation on the TITAN clinical trials, concluding with an interactive discussion period. Delve into this comprehensive 92-minute session from the University of Ottawa Heart Institute that combines expert presentations with collaborative dialogue to advance understanding of genetic aortopathy diagnosis and treatment approaches.
Genetic Aortopathy - Updates from 2022 AHA/ACC Guidelines and TITAN Clinical Trials
University of Ottawa Heart Institute via YouTube
Overview
Syllabus
- Genetic aortopathy: update from the 2022 AHA/ACC guidelines: Dr. Kenza Rahmouni, University of Ottawa Heart Institute
- Group discussion
- All Bridging the evidence gap in aortic disease - the TITAN clinical trials: Dr. Munir Boodhwani, University of Ottawa Heart Institute
- Group discussion
Taught by
University of Ottawa Heart Institute
